Indeed, middle east respiratory syndrome–related coronavirus (MERS CoV), SARS–CoV, and influenza patients with ARDS not only show higher levels of IL-1β in bronchoalveolar fluid and plasma as compared to healthy controls, but this condition is also associated with worse clinical outcomes [78,79,80]. This evidence concerns the gene IL1B and acute respiratory distress syndrome.